Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cytosorbents (CTSO) Inventory Average (2016 - 2025)

Cytosorbents (CTSO) has disclosed Inventory Average for 13 consecutive years, with $2.9 million as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Inventory Average fell 22.47% year-over-year to $2.9 million, compared with a TTM value of $2.9 million through Mar 2025, down 22.47%, and an annual FY2024 reading of $3.2 million, down 10.2% over the prior year.
  • Inventory Average was $2.9 million for Q1 2025 at Cytosorbents, down from $3.0 million in the prior quarter.
  • Across five years, Inventory Average topped out at $5.2 million in Q2 2022 and bottomed at $1.9 million in Q2 2023.
  • Average Inventory Average over 5 years is $3.6 million, with a median of $3.5 million recorded in 2022.
  • The sharpest move saw Inventory Average tumbled 63.82% in 2023, then soared 113.58% in 2024.
  • Year by year, Inventory Average stood at $4.6 million in 2021, then fell by 24.65% to $3.5 million in 2022, then decreased by 4.94% to $3.3 million in 2023, then dropped by 10.16% to $3.0 million in 2024, then dropped by 3.83% to $2.9 million in 2025.
  • Business Quant data shows Inventory Average for CTSO at $2.9 million in Q1 2025, $3.0 million in Q4 2024, and $3.8 million in Q3 2024.